KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Short-term Investments (2016 - 2026)

Pfizer has reported Short-term Investments over the past 18 years, most recently at $11.4 billion for Q1 2026.

  • Quarterly Short-term Investments fell 28.42% to $11.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.4 billion through Mar 2026, down 28.42% year-over-year, with the annual reading at $12.5 billion for FY2025, 35.92% down from the prior year.
  • Short-term Investments was $11.4 billion for Q1 2026 at Pfizer, down from $12.5 billion in the prior quarter.
  • Over five years, Short-term Investments peaked at $42.2 billion in Q3 2023 and troughed at $6.0 billion in Q2 2024.
  • The 5-year median for Short-term Investments is $15.9 billion (2025), against an average of $19.5 billion.
  • The largest YoY upside for Short-term Investments was 97.56% in 2024 against a maximum downside of 85.65% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $22.3 billion in 2022, then tumbled by 55.92% to $9.8 billion in 2023, then skyrocketed by 97.56% to $19.4 billion in 2024, then tumbled by 35.92% to $12.5 billion in 2025, then fell by 8.69% to $11.4 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Short-term Investments are $11.4 billion (Q1 2026), $12.5 billion (Q4 2025), and $13.6 billion (Q3 2025).